Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting

被引:121
作者
Scazzocchio, Elena [1 ,2 ,3 ]
Figueras, Francesc [1 ,2 ]
Crispi, Fatima [1 ,2 ]
Meler, Eva [1 ,2 ,3 ]
Masoller, Narcs [1 ,2 ]
Mula, Raquel [1 ,2 ]
Gratacos, Eduard [1 ,2 ]
机构
[1] Univ Barcelona, Dept Maternal Fetal Med, Inst Clin Gynecol Obstet & Neonatol, Hosp Clin,Inst Invest Biomed August Pi & Sunyer, E-08028 Barcelona, Spain
[2] Ctr Biomed Res Rare Dis CIBER ER, Barcelona, Spain
[3] Inst Univ Dexeus, Dept Obstet Gynecol & Reprod Med, Barcelona, Spain
关键词
blood pressure; preeclampsia; screening; uterine artery Doppler; UTERINE ARTERY DOPPLER; HYPERTENSIVE DISORDERS; PAPP-A; BIOCHEMICAL MARKERS; GROWTH RESTRICTION; BLOOD-PRESSURE; PREGNANCY; PREDICTION; GESTATION; CLASSIFICATION;
D O I
10.1016/j.ajog.2012.12.016
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: We sought to evaluate the effectiveness of an integrated first-trimester screening test to predict preeclampsia (PE). STUDY DESIGN: A prospective cohort of singleton pregnancies underwent routine first-trimester screening from 2009 through 2011 (n = 5759). A logistic regression-based predictive model for early-and late-onset PE was constructed based on: maternal characteristics; levels of pregnancy-associated plasma protein-A and free beta-human chorionic gonadotropin at 8-12 weeks; and blood pressure and uterine artery Doppler at 11.0-13.6 weeks. RESULTS: Of the 5170 enrolled participants, 136 (2.6%) developed PE (early PE: 26 [0.5%]; late PE: 110 [2.1%]). At 5% and 10% false-positive rates, detection rates were 69.2% and 80.8% for early PE (area under the curve, 0.95; 95% confidence interval, 0.94-0.98) and 29.4% and 39.6% for late PE (area under the curve, 0.71; 95% confidence interval, 0.66-0.76), respectively. CONCLUSION: First-trimester screening combining maternal factors with uterine artery Doppler, blood pressure, and pregnancy-associated plasma protein-A is useful to predict PE in a routine care setting.
引用
收藏
页码:203.e1 / 203.e10
页数:10
相关论文
共 29 条
[1]   Maternal plasma inhibin A at 11-13 weeks of gestation in hypertensive disorders of pregnancy [J].
Akolekar, Ranjit ;
Minekawa, Ryoko ;
Veduta, Alina ;
Romero, Ximena C. ;
Nicolaides, Kypros H. .
PRENATAL DIAGNOSIS, 2009, 29 (08) :753-760
[2]   The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) [J].
Brown, MA ;
Lindheimer, MD ;
de Swiet, M ;
Van Assche, A ;
Moutquin, JM .
HYPERTENSION IN PREGNANCY, 2001, 20 (01) :IX-XIV
[3]   Acetylsalicylic Acid for the Prevention of Preeclampsia and Intra-uterine Growth Restriction in Women with Abnormal Uterine Artery Doppler: A Systematic Review and Meta-analysis [J].
Bujold, Emmanuel ;
Morency, Anne-Maude ;
Roberge, Stephanie ;
Lacasse, Yves ;
Forest, Jean-Claude ;
Giguere, Yves .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2009, 31 (09) :818-826
[4]  
Casals E, 1999, PRENATAL DIAG, V19, P8, DOI 10.1002/(SICI)1097-0223(199901)19:1<8::AID-PD460>3.0.CO
[5]  
2-1
[6]   Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction [J].
Crispi, Fatima ;
Dominguez, Carmen ;
Llurba, Elisa ;
Martin-Gallan, Pitar ;
Cabero, Luis ;
Gratacos, Eduard .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (01) :201-207
[7]   Screening for Pre-eclampsia-Lessons from Aneuploidy Screening [J].
Cuckle, H. S. .
PLACENTA, 2011, 32 :S42-S48
[8]   The Global Impact of Pre-eclampsia and Eclampsia [J].
Duley, Lelia .
SEMINARS IN PERINATOLOGY, 2009, 33 (03) :130-137
[9]   Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia [J].
Foidart, J. -M. ;
Munaut, C. ;
Chantraine, F. ;
Akolekar, R. ;
Nicolaides, K. H. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2010, 35 (06) :680-687
[10]   Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study [J].
Gardosi, J ;
Kady, SM ;
McGeown, P ;
Francis, A ;
Tonks, A .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7525) :1113-1117